- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Disposable Medical Prod
Rochester Medical Corp
+ Add to WatchlistRM5:GR
11.390 EUR 0.200 1.79%As of 02:08:42 ET on 05/20/2013.
Snapshot for Rochester Medical Corp (RM5)
| Open: | 11.390 | Day's Range: | 11.390 - 11.390 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 11.190 | 52wk Range: | 7.053 - 11.400 | 1-Yr Rtn: | +44.93% |
Key Statistics for RM5
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(09/2013) | 31.8400 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (09/2013) | 0.4600 |
| Est. PEG Ratio | 1.5920 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 31 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RM5
Company Profile & Key Executives for RM5
Rochester Medical Corporation develops, manufactures and markets latex free disposable urinary continence care products. The products are used for urinary dysfunction management and urine drainage management. The Company markets its products under its Rochester Medical brand and private label arrangements.
| Anthony J ConwayChairman/President/CEO | David A JonasCFO/Treasurer/Secretary |
| Martyn R SholtisVice President | Philip J ConwayVP:Production Technologies |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
RM5 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page